Cancer Management And Research

Cancer Management And Research

癌症管理与研究

  • 4区 中科院分区
  • Q3 JCR分区

期刊简介

《Cancer Management And Research》是由Dove Medical Press Ltd.出版社于2009年创办的英文国际期刊(ISSN: 1179-1322,E-ISSN: 1179-1322),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为Medicine-Oncology。作为SCIE收录期刊(JCR分区 Q3,中科院 4区),本刊采用OA开放获取模式(OA占比1%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比67.57%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在111篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Cancer Management And Research审稿周期约为 16 Weeks 。该刊近年被列入国际预警名单,年发文量约111篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 111 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
ONCOLOGY 肿瘤学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
ONCOLOGY 肿瘤学
4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q3 183 / 322

43.3%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q3 180 / 322

44.25%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:7.4 SJR:0.675 SNIP:0.668
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q1 91 / 404

77%

期刊发文

  • Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients Treated with Definitive Chemoradiotherapy for Locally Advanced Oesophageal Squamous Cell Carcinoma

    Author: Zhang, Guojun; Yang, Chuan; Zhao, Caixia; Xian, Feng; Qing, Dong; Guo, Qiyu; Song, Junmei; Liu, Xilin; Bie, Jun

    Journal: CANCER MANAGEMENT AND RESEARCH. 2023; Vol. 15, Issue , pp. 101-112. DOI: 10.2147/CMAR.S395191

  • Implication of Ferroptosis in Cholangiocarcinoma: A Potential Future Target?

    Author: Yang, Mingyu; Li, Meng; Lyu, Zhuozhen; Yang, Zhen

    Journal: CANCER MANAGEMENT AND RESEARCH. 2023; Vol. 15, Issue , pp. 335-342. DOI: 10.2147/CMAR.S406150

  • Enhanced Glycolysis Confers Resistance Against Photon but Not Carbon Ion Irradiation in Human Glioma Cell Lines

    Author: Vashishta, Mohit; Kumar, Vivek; Guha, Chandan; Wu, Xiaodong; Dwarakanath, Bilikere S.

    Journal: CANCER MANAGEMENT AND RESEARCH. 2023; Vol. 15, Issue , pp. 1-16. DOI: 10.2147/CMAR.S385968

  • TP63 Functions as a Tumor Suppressor Regulated by GAS5/miR-221-3p Signaling Axis in Human Non-Small Cell Lung Cancer Cells

    Author: Shen, Qiming; Wang, Haoyou; Zhang, Lin

    Journal: CANCER MANAGEMENT AND RESEARCH. 2023; Vol. 15, Issue , pp. 217-231. DOI: 10.2147/CMAR.S387781

  • The Role of Perioperative C-Reactive Protein in Predicting the Prognosis of Epithelial Ovarian Carcinoma

    Author: Pan, Qianqian; Wei, Mingjing; Lu, Mengyi; Xu, Yaping; Xie, Xing; Li, Xiao

    Journal: CANCER MANAGEMENT AND RESEARCH. 2023; Vol. 15, Issue , pp. 233-243. DOI: 10.2147/CMAR.S385974

  • Comparison of the Incidence Rate of Radiation Pneumonitis Observed in Patients with Advanced Lung Adenocarcinoma Treated with Simultaneous Thoracic Radiotherapy and 1G/2G/3G EGFR-TKIs

    Author: Mu, Fengchun; Fan, Bingjie; Li, Butuo; Qin, Wenru; Li, Haoqian; Wang, Chunni; Zou, Bing; Wang, Shijiang; Wang, Linlin

    Journal: CANCER MANAGEMENT AND RESEARCH. 2023; Vol. 15, Issue , pp. 351-362. DOI: 10.2147/CMAR.S404874

  • Rare Combined Small Cell Lung Carcinoma and Lung Squamous Cell Carcinoma Response to PD-1 Inhibitor as Third-Line Therapy: A Case Report

    Author: Liu, Zhisheng; Zhang, Junling; Ge, Yunjie; Huang, Mengli; Wang, Ye

    Journal: CANCER MANAGEMENT AND RESEARCH. 2023; Vol. 15, Issue , pp. 197-201. DOI: 10.2147/CMAR.S397711

  • Mutational and Transcriptional Characterization Establishes Prognostic Models for Resectable Lung Squamous Cell Carcinoma

    Author: Liu, Yinqiang; Duan, Jin; Zhang, Fujun; Liu, Fanghao; Luo, Xiaoyu; Shi, Yunfei; Lei, Youming

    Journal: CANCER MANAGEMENT AND RESEARCH. 2023; Vol. 15, Issue , pp. 147-163. DOI: 10.2147/CMAR.S384918